COL18A1 and non-small cell lung carcinoma: Furthermore, the baseline serum levels of CEA may potentially function as a predictor for the efficacy of rh-endostatin when combined with chemotherapy in NSCLC patients.<h4>Clinicaltrials</h4>GOV: NCT05574998.